DrugDashboards

Caspofungin Acetate

Caspofungin Acetate · CASPOFUNGIN ACETATE 5 mg/mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

NDC 65897-0002-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 10.8 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

8 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 72266-0106-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$60.51per unit
middle half $53.89–$85.29 · 4,227 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $60.51
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
77%of plans cover it
tier 4 · prior auth 10% · step therapy 0% · qty limit 0%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 6 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $364.53 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA216506
TE code
AP
Approval date
Jul 18, 2025
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Caspofungin Acetate, Injection, 5 mg/1 mL (NDC 0781-3421-94)Jun 30, 2026
  • Planned discontinuation — Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 0781-3423-94)Jun 30, 2026
  • Planned discontinuation — Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 63323-358-10)Jan 12, 2026

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Caspofungin Acetate (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Fosun Pharma USA Inc.CASPOFUNGIN ACETATE 7 mg/mLJul 15, 2026Sep 2, 2026
Fosun Pharma USA Inc.CASPOFUNGIN ACETATE 5 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCCASPOFUNGIN ACETATE 5 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCCASPOFUNGIN ACETATE 7 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedCASPOFUNGIN ACETATE 5 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedCASPOFUNGIN ACETATE 7 mg/mLJul 15, 2026Sep 2, 2026
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.CASPOFUNGIN ACETATE 7 mg/mLJul 15, 2026Sep 2, 2026
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.CASPOFUNGIN ACETATE 5 mg/mLJul 15, 2026Sep 2, 2026
Merck Sharp & Dohme Corp.CASPOFUNGIN ACETATE 1 kg/kgJul 15, 2026Sep 2, 2026
Merck Sharp & Dohme LLCCASPOFUNGIN ACETATE 5 mg/mLJul 15, 2026Sep 2, 2026
Merck Sharp & Dohme LLCCASPOFUNGIN ACETATE 7 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsCASPOFUNGIN ACETATE 5 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsCASPOFUNGIN ACETATE 7 mg/mLJul 15, 2026Sep 2, 2026
Sandoz IncCASPOFUNGIN ACETATE 7 mg/mLJul 15, 2026Sep 2, 2026
Sandoz IncCASPOFUNGIN ACETATE 5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Caspofungin Acetate — NDC 65897-0002-01," retrieved September 3, 2026, https://drugdashboards.com/drug/65897000201.

Free to cite with attribution — see how the data is put together.